Edaravone should be administered intravenously (IV). Patients receive the drug every day for two weeks, then take a break (‘drug holiday’) for a couple of weeks, followed by ten-day sessions of the treatment every month. Ideally, initial couple of treatment courses should be given in the hospital for safety purposes, including the potential side effects to the drug.
Edaravone side effects
Most common adverse reactions include bruising, gait disturbances, headache, skin inflammation, eczema, problems breathing, excess sugar in urine, and fungal skin infections.
Warnings and Precautions
- The medication is being prescribed by a neurologist that specializes in ALS or neuromuscular disorders.
- It is unspecified that this drug is safe and effective in children.
- Do not receive this drug if you are allergic to edaravone or any of the ingredients of it.
- Inform your doctor before taking inj Edaravone if you are breastfeeding or plan to breastfeed.
- Inform your healthcare provider immediately or go to the nearest emergency room if you experience any of the symptoms such as swelling of the lips, hives, tongue, or face; fainting; wheezing; breathing problems; trouble swallowing; itching; dizziness; or an asthma attack (in people with the asthma).
- Reactions of hypersensitivity have been reported in people receiving Edastar injection and could happen after your infusion is finished.
- Patients should be monitored by their healthcare professional during the treatment and should be watched for the signs and symptoms of all the serious side effects.
Supplied/Storage and handling
Care should be exercised in the handling of this drug. EDASTAR injection should not be opened or crushed. Store permitted between 15-30°C (59-86°F).
Commonly asked questions:
The U.S. FDA approved Edaravone injection as an intravenous infusion treatment option for treating amyotrophic lateral sclerosis (ALS). To help people recover from the stroke is another Edaravone uses.
The mechanism by which Edaravone exerts its therapeutic effect in patients with Amyotrophic Lateral Sclerosis (ALS) is unknown.
Edaravone is the active ingredient, and the inactive ingredients are L-cysteine hydrochloride hydrate, sodium bisulfite, sodium chloride, phosphoric acid and sodium hydroxide.
Mitsubishi Tanabe Pharma Corporation has discovered and developed this drug.
Yes, Edaravone als is the US FDA (Food and Drug Administration) approved medication.
Bruise (contusion), problems walking (gait disturbance), and headache are the most common side effects.
- You can buy Edaravone from any authorized whole seller after getting prescription from a qualified doctor. It is always better to check the credential of the whole seller/supplier/exporter before buying the product.
- The buyer should check the existing law in their home country before importing the product.
Patients can simply fill the order form or can send mail at email@example.com. Patient can also send WhatsApp message to +91 8130290915. We will reply ASAP with the details of Pricing and procedure.
Note:- The order will be confirmed only after the receipt of Valid prescription of Clinician
Edaravone injection should not be opened or crushed.
Store the medicine between 15-30°C (59-86°F).
All Trademark and Brand that appear on the website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. Edaravone is a pharmaceutical drug that legally requires a medical prescription to be dispensed.
Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller and Pharmacies.